Issue : 4 October 2007
View all stories from this issue.
Public consultation: knowing your obligationsSubscription
Confusion often arises over NHS bodies' consultation obligations, but upcoming legislation makes it ever more important to get these right, says Trevor Blythe
David Praill on access to pain reliefSubscription
According to our report Access to Pain Relief – an essential human right, published this week to mark World Hospice and Palliative Care Day on 6 October, 80 per cent of the world’s cancer sufferers have no access to pain relief. This means 7 per cent of the world's population is experiencing cancer pain that could be relieved but is not, due to lack of access to drugs that are low in cost, easy to administer and highly effective.
NICE chief asks for divorce from DoHSubscription
The chief executive of the National Institute for Health and Clinical Excellence has said that it would function better if it were set free from the Department of Health.
Councillors to join PCT boardsSubscription
Primary care trusts might be told to have local authority councillors on their boards, health minister Ben Bradshaw told delegates.
Going off OfcareSubscription
Ministers are not keen on the proposed name for the new health and social care regulator, Ofcare.
Moves to strengthen confidentiality for young people have been hailed as a step forward in efforts to bring down teenage pregnancy rates.
A clinical vision for service redesignSubscription
When clinicians were asked to design their ideal service, common design rules quickly emerged. As Nigel Edwards and William Dunlop explain, these closely matched the views of patients
A year after their first publication, the NHS Better Care, Better Value indicators are starting to reflect efforts to improve the efficiency of NHS care.
Media Watch: GP contracts and doctored photosSubscription
As the party conference season drew to a close, the Conservatives this week came out fighting, with leader David Cameron pledging to rewrite the GP contract.
Appeal against Alzheimer's drug decisionSubscription
Pharmaceutical companies are appealing a High Court judgement that upheld the National Institute for Health and Clinical Excellence's decision to restrict the use of anti-dementia medicines for NHS patients in the early stages of Alzheimer's disease.